Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.8K
Overview
51.8K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trial.

Neuro-oncology practiceยท2026
Same author

Seizure prophylaxis in glioma surgery: a synopsis from the SPRING RCT.

Health technology assessment (Winchester, England)ยท2026
Same author

Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas.

Neuro-oncologyยท2026
Same author

Introduction of whole genome sequencing as NHS standard of care for glioma patients in two neurosurgical oncology centres: West Midlands.

BJC reportsยท2025
Same author

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

Neuro-oncologyยท2025
Same author

Core Outcome Sets for Meningioma In Clinical studies (COSMIC): An international patient and healthcare professional consensus for research studies.

Neuro-oncology practiceยท2025

Related Experiment Video

Updated: Feb 8, 2026

Vaccines, APCs and Memory Cells
01:51

Vaccines, APCs and Memory Cells

51.8K

Phagosome neutrality in host defense.

Colin Watts1

  • 1Wellcome Trust Biocentre, School of Life Sciences, University of Dundee, Dundee DD1 5EH. c.watts@dundee.ac.uk

Cell
|July 15, 2006
PubMed
Summary
This summary is machine-generated.

Dendritic cell phagosomes recruit NADPH oxidase, which neutralizes pH. This pH change reduces protease activity, preserving antigens for crosspresentation on MHC class I molecules.

More Related Videos

Cancer Vaccines
01:30

Cancer Vaccines

1.1K

Related Experiment Videos

Last Updated: Feb 8, 2026

Vaccines, APCs and Memory Cells
01:51

Vaccines, APCs and Memory Cells

51.8K
Cancer Vaccines
01:30

Cancer Vaccines

1.1K

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Neutrophil phagosomes activate proteases via pH neutralization by NADPH oxidase.
  • Dendritic cells are crucial antigen-presenting cells in adaptive immunity.

Purpose of the Study:

  • To investigate the role of NADPH oxidase in dendritic cell phagosomal function.
  • To understand the impact of phagosomal pH on antigen processing in dendritic cells.

Main Methods:

  • Analysis of phagosomal pH dynamics in dendritic cells.
  • Assessment of protease activity within dendritic cell phagosomes.
  • Evaluation of antigen crosspresentation on MHC class I molecules.

Main Results:

  • Dendritic cell phagosomes recruit NADPH oxidase, similar to neutrophils.
  • Phagosomal pH neutralization in dendritic cells decreases protease activity.
  • Reduced protease activity preserves antigens for crosspresentation.

Conclusions:

  • Dendritic cell phagosomal pH regulation by NADPH oxidase differs from neutrophils.
  • This mechanism enhances antigen preservation for crosspresentation on MHC class I.
  • This finding offers insights into dendritic cell-mediated immune responses.